Analgesia for Neuropathic Pain by Dorsal Root Ganglion Transplantation of Genetically Engineered Mesenchymal Stem Cells: Initial Results
Background Cell-based therapy may hold promise for treatment of chronic pain. Mesenchymal stem cells (MSCs) are readily available and robust, and their secretion of therapeutic peptides can be enhanced by genetically engineering. We explored the analgesic potential of transplanting bone marrow-deriv...
| 發表在: | Molecular Pain |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
SAGE Publishing
2015-02-01
|
| 在線閱讀: | https://doi.org/10.1186/s12990-015-0002-9 |